Is Levarterenolo [DCIT] Safe in Breastfeeding

Question

I am a breastfeeding mother and i want to know if it is safe to use Levarterenolo [DCIT]? Is Levarterenolo [DCIT] safe for nursing mother and child? Does Levarterenolo [DCIT] extracts into breast milk? Does Levarterenolo [DCIT] has any long term or short term side effects on infants? Can Levarterenolo [DCIT] influence milk supply or can Levarterenolo [DCIT] decrease milk supply in lactating mothers?

Levarterenolo [DCIT] lactation summary

Levarterenolo [DCIT] is safe in breastfeeding

DrLact safety Score for Levarterenolo [DCIT] is 1 out of 8 which is considered Safe as per our analyses.
A safety Score of 1 indicates that usage of Levarterenolo [DCIT] is mostly safe during lactation for breastfed baby.
Our study of different scientific research also indicates that Levarterenolo [DCIT] does not cause any serious side effects in breastfeeding mothers.
Most of scientific studies and research papers declaring usage of Levarterenolo [DCIT] safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Levarterenolo [DCIT] usage in lactation

It is destroyed within the gastrointestinal tract. Systemically used on CPR, and locally for topical anesthesia, ophtalmic drops (mydriatic) and nasal drops (vasoconstriction).

Answer by DrLact: About Levarterenolo [DCIT] usage in lactation

No information is available on the use of Levarterenolo [DCIT] during breastfeeding. Because of its poor oral bioavailability and short half-life, any Levarterenolo [DCIT] in milk is unlikely to affect the infant. High intravenous doses of Levarterenolo [DCIT] might reduce milk production or milk letdown.

Levarterenolo [DCIT] Possible Effects in Breastfeeding

Relevant published information in nursing mothers was not found as of the revision date. Animal data indicate that Levarterenolo [DCIT] can decrease serum prolactin and reduce milk production,[1] as well as inhibit the release of oxytocin, which inhibits milk ejection.[2]